Mapping EORTC QLQ-C30 and QLQ-MY20 to EQ-5D in patients with multiple myeloma

Health-related quality of life in elderly, newly diagnosed multiple myeloma patients treated with VMP vs. MP: results from the VISTA trial

(2012) Michel Delforge et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Lenalidomide, melphalan, and prednisone, followed by lenalidomide maintenance, improves health-related quality of life in newly diagnosed multiple myeloma patients aged 65 years or older: results of a randomized phase III trial

(2012) M. A. Dimopoulos et al.   HAEMATOLOGICA

The ability of cancer-specific and generic preference-based instruments to discriminate across clinical and self-reported measures of cancer severities

(2011) Paulos Teckle et al.   Health and Quality of Life Outcomes

Mapping QLQ-C30, HAQ, and MSIS-29 on EQ-5D

(2011) Matthijs M. Versteegh et al.   MEDICAL DECISION MAKING

Mapping the cancer-specific EORTC QLQ-C30 and EORTC QLQ-BR23 to the generic EQ-5D in metastatic breast cancer patients

(2011) Eun-ju Kim et al.   QUALITY OF LIFE RESEARCH

Utility values in National Institute for Health and Clinical Excellence (NICE) Technology Appraisals

(2011) Jonathan C. Tosh et al.   VALUE IN HEALTH

Deriving a Preference-Based Measure for Cancer Using the EORTC QLQ-C30

(2011) Donna Rowen et al.   VALUE IN HEALTH

Mapping the Cancer-Specific EORTC QLQ-C30 to the Preference-Based EQ-5D, SF-6D, and 15D Instruments

(2009) Nick Kontodimopoulos et al.   VALUE IN HEALTH

Mapping the EORTC QLQ C-30 onto the EQ-5D Instrument: The Potential to Estimate QALYs without Generic Preference Data

(2008) Lynda McKenzie et al.   VALUE IN HEALTH